The Psychedelic Revolution Is Coming. Psychiatry May Never Be the Same (New York Times).
Summary: MAPS is featured in an article on the front page of today's edition of The New York Times!
Reporter Andrew Jacobs profiles MAPS Founder and...
Advances in Psychedelics can Change Investors’ Minds
Original article(s) on EXBulletin and Financial Times
The science behind this subject has become mainstream in recent years. Excellent BBC documentary Psychedelic trial We explored the implications...
That’s it. $225 Million Raised by Atai (ATAI) Gets us Interested in the Psychedelics...
Redefining how the world approaches, prevents, and heals mental health disorders.
LIVE QUOTE
Initially founded as a holding group that later became involved in operations, Atai...
CBS News: Inside a Psychedelic Ketamine Therapy Sessions (Video).
Therapy Treatment Performed by Ehave's (EHVVF) Chief Medical Office Receive Rave Reviews and Offers Potential to Save Lives,
MIAMI BEACH, Fla. (CBS12) — Last month, the...
Why Isn’t Big Pharma Jumping Into Psychedelics (PsyTech).
Originally in PsyTech Jan 28, 2021.
By Tessa Eskin
Big Pharma is at a crossroads. The industry’s business model relies largely on returning customers for...
Latest article
Adding BCM Resources Corporation (B.V) $0.27, Up 42%, to Watch List.
'Elephant Hunter' Dr. Sergei Diakov is Expanding Drill Footprint, to Outline a Potentially Massive Copper-Gold System Beneath the Surface.
Led by legendary geologist Dr. Sergei...
New Report on Sekur Private Data (SWISF). Palantir’s Open Secure AI.
Palantir CEO Alex Karp discusses open-weight artificial intelligence models, how he believes the technology should be regulated and why the U.S. should avoid Europe’s...
Replimune (REPL) Jumps 100%.
A Nifty $415 Million Gain (in an hour) for Shareholders.
Not out of the woods yet..
Short and to the point: We listened to whole meeting...
